HERON THERAPEUTICS, INC. /DE/ Lessee, Operating Lease, Liability, to be Paid, Year One
HERON THERAPEUTICS, INC. /DE/ (HRTX) had Lessee, Operating Lease, Liability, to be Paid, Year One of $576.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-08-10
- 2026-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $576.00K.
- 2024-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $3.14M.
- 2024-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $3.14M.
- 2024-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $3.14M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2026-06-30 | $576.00K 10-Q · filed 2026-08-10 |
| 2024-09-30 | $3.14M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $3.14M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $3.14M 10-Q · filed 2024-05-07 |
| 2023-09-30 | $3.15M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $3.03M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $3.03M 10-Q · filed 2023-05-11 |
| 2022-09-30 | $2.97M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $2.97M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $2.97M 10-Q · filed 2022-05-09 |
| 2021-09-30 | $4.06M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $4.06M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $4.06M 10-Q · filed 2021-05-10 |
| 2020-09-30 | $3.94M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $3.94M 10-Q · filed 2020-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |